Neuronal ceroid lipofuscinoses

Handbook of Clinical Neurology

Volumn 113, Issue , 2013, Pages 1701-1706

  Chabrol, Brigitte ^a   Caillaud, Catherine ^b   Minassian, Berge ^c  

^a TIMONE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876848155     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59565-2.00038-1     Document Type: Chapter

References (19)

1. Anderson W.A., Goebel H.H., Simonati A. Human pathology in NCL. Biochem Biophys Acta 2013, (in press,). http://dx.doi.org/10.1016/j.bbadis.2012.11.014.
2. Cooper J.D., Russell C., Mitchison H.M. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 2006, 1762:873-889.
3. Goebel H.H., Wisniewski K.E. Current state of clinical and morphological features in human NCL. Brain Pathol 2004, 14:61-69.
4. Griffey M.A., Wozniak D., Wong M., et al. CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther 2006, 13:538-547.
5. Holmberg V., Lauronen L., Autti T., et al. Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology 2000, 55:579-581.
6. Jarvela I., Autti T., Lamminranta S., et al. Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Ann Neurol 1997, 42:799-802.
7. Lauronen L., Munroe P.B., Jarvela I., et al. Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology 1999, 52:360-365.
8. Lonnqvist T., Vanhanen S.L., Vettenranta K., et al. Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis. Neurology 2001, 57:1411-1416.
9. Mole S.E., Williams R.E., Goebel H.H. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 2005, 6:107-126.
10. Narayan S.B., Rakheja D., Tan L., et al. CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 desaturase. Ann Neurol 2006, 60:570-577.
11. Ranta S., Topcu M., Tegelberg S., et al. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat 2004, 23:300-305.
12. Santavuori P., Haltia M., Rapola J., et al. Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients. J Neurol Sci 1973, 18:257-267.
13. Siintola E., Topcu M., Aula N., et al. The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. Am J Hum Genet 2007, 81:136-146.
14. Sleat D.E., Donnelly R.J., Lackland H., et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 1997, 277:1802-1805.
15. Steinfeld R., Reinhardt K., Schreiber K., et al. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 2006, 78:988-998.
16. Vesa J., Hellsten E., Verkruyse L.A., et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995, 376:584-587.
17. Wheeler R.B., Sharp J.D., Schultz R.A., et al. The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am J Hum Genet 2002, 70:537-542.
18. Williams R.E., Gottlob I., Lake B.D., et al. Classic late infantile NCL. The Neuronal Ceroid Lipofuscinoses (Batten Disease) 1999, 37-54. IOS Press, Amsterdam. H.H. Goebel, S.E. Mole, B.D. Lake (Eds.).
19. Wisniewski K.E., Kaczmarski A., Kida E., et al. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab 1999, 66:248-252.